PD Dr. Danijel Sikic


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing (2024) Angeloni M, van Doeveren T, Lindner S, Volland P, Schmelmer J, Foersch S, Matek C, et al. Journal article Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes. (2024) Eckstein M, Matek C, Wagner P, Erber R, Büttner-Herold M, Wild PJ, Taubert H, et al. Journal article Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts (2024) Bahlinger V, Branz A, Strissel P, Strick R, Lange F, Geppert CI, Klümper N, et al. Journal article C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma (2022) Klümper N, Sikic D, Saal J, Büttner T, Goldschmidt F, Jarczyk J, Becker P, et al. Journal article Analysis of the Impact of Clinical Factors on Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction (2022) Oginski N, Apel H, Richterstetter M, Lieb V, Fiebig C, Goebell P, Wullich B, Sikic D Journal article Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients (2021) Eckstein M, Lieb V, Jung R, Sikic D, Weigelt K, Stöhr R, Geppert CI, et al. Journal article Integration of spatial pd-l1 expression with the tumor immune microenvironment outperforms standard pd-l1 scoring in outcome prediction of urothelial cancer patients (2021) Weyerer V, Strissel P, Strick R, Sikic D, Geppert CI, Bertz S, Lange F, et al. Journal article, Original article Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy (2021) Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, et al. Journal article